Latest Insider Transactions at Sleep Number Corp (SNBR)
This section provides a real-time view of insider transactions for Sleep Number Corp (SNBR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sleep Number Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sleep Number Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 12
2021
|
Daniel Alegre Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,019
+2.04%
|
$54,007
$53.27 P/Share
|
|
May 12
2021
|
Stephen L Gulis Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+2.89%
|
-
|
|
May 12
2021
|
Michael J Harrison Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+1.93%
|
-
|
|
May 12
2021
|
Julie Howard Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+14.32%
|
-
|
|
May 12
2021
|
Deborah L. Kilpatrick Director |
BUY
Bona fide gift
|
Indirect |
1,815
+14.45%
|
-
|
|
May 12
2021
|
Deborah L. Kilpatrick Director |
SELL
Bona fide gift
|
Direct |
1,815
-68.88%
|
-
|
|
May 12
2021
|
Deborah L. Kilpatrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+23.73%
|
-
|
|
May 12
2021
|
Brenda J Lauderback Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+2.33%
|
-
|
|
May 12
2021
|
Barbara Ruth Matas Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+4.0%
|
-
|
|
May 12
2021
|
Kathleen L Nedorostek Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+4.65%
|
-
|
|
May 12
2021
|
Jean Michel Valette Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+0.37%
|
-
|
|
May 04
2021
|
Samuel R Hellfeld EVP Chief Legal & Risk Officer |
BUY
Discretionary transaction
|
Indirect |
330
+13.47%
|
$36,300
$110.69 P/Share
|
|
Apr 30
2021
|
Shelly Radue Ibach President and CEO |
BUY
Bona fide gift
|
Indirect |
14,465
+8.82%
|
-
|
|
Apr 30
2021
|
Shelly Radue Ibach President and CEO |
SELL
Bona fide gift
|
Direct |
14,465
-14.12%
|
-
|
|
Apr 30
2021
|
Shelly Radue Ibach President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,465
+12.37%
|
$477,345
$33.32 P/Share
|
|
Apr 05
2021
|
Jean Michel Valette Director |
SELL
Open market or private sale
|
Direct |
25,000
-10.1%
|
$3,425,000
$137.7 P/Share
|
|
Apr 01
2021
|
Shelly Radue Ibach President and CEO |
SELL
Open market or private sale
|
Indirect |
2,930
-2.12%
|
$421,920
$144.75 P/Share
|
|
Mar 29
2021
|
Christopher D Krusmark EVP & Chief H.R. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
69
-0.66%
|
$9,384
$136.21 P/Share
|
|
Mar 29
2021
|
Christopher D Krusmark EVP & Chief H.R. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
223
+2.08%
|
-
|
|
Mar 29
2021
|
Robert Joseph Poirier VP, CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
50
-2.04%
|
$6,800
$136.21 P/Share
|
|
Mar 29
2021
|
Robert Joseph Poirier VP, CAO |
BUY
Grant, award, or other acquisition
|
Direct |
161
+6.17%
|
-
|
|
Mar 25
2021
|
Melissa Barra EVP, Chief Sales & Services |
SELL
Open market or private sale
|
Direct |
1,274
-2.99%
|
$161,798
$127.42 P/Share
|
|
Mar 22
2021
|
David R Callen EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,045
-12.12%
|
$846,300
$140.63 P/Share
|
|
Mar 21
2021
|
Melissa Barra EVP, Chief Sales & Services |
SELL
Payment of exercise price or tax liability
|
Direct |
4,901
-10.33%
|
$700,843
$143.83 P/Share
|
|
Mar 21
2021
|
Melissa Barra EVP, Chief Sales & Services |
BUY
Grant, award, or other acquisition
|
Direct |
11,265
+19.19%
|
-
|
|
Mar 21
2021
|
Andrea Lee Bloomquist EVP, Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,929
-7.6%
|
$847,847
$143.83 P/Share
|
|
Mar 21
2021
|
Andrea Lee Bloomquist EVP, Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,516
+14.76%
|
-
|
|
Mar 21
2021
|
Kevin Kennedy Brown EVP and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,241
-8.88%
|
$463,463
$143.83 P/Share
|
|
Mar 21
2021
|
Kevin Kennedy Brown EVP and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
13,516
+27.02%
|
-
|
|
Mar 21
2021
|
David R Callen EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,042
-12.37%
|
$1,007,006
$143.83 P/Share
|
|
Mar 21
2021
|
David R Callen EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
15,774
+21.7%
|
-
|
|
Mar 21
2021
|
Shelly Radue Ibach President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,118
-2.35%
|
$302,874
$143.83 P/Share
|
|
Mar 21
2021
|
Shelly Radue Ibach President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
90,127
+50.0%
|
-
|
|
Mar 21
2021
|
Samuel R Hellfeld EVP Chief Legal & Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-6.86%
|
$88,088
$143.83 P/Share
|
|
Mar 21
2021
|
Samuel R Hellfeld EVP Chief Legal & Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,800
+16.7%
|
-
|
|
Mar 21
2021
|
Christopher D Krusmark EVP & Chief H.R. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
685
-6.24%
|
$97,955
$143.83 P/Share
|
|
Mar 21
2021
|
Christopher D Krusmark EVP & Chief H.R. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,001
+15.43%
|
-
|
|
Mar 21
2021
|
Joseph Hunter Saklad EVP, Chief Supply Chain Office |
SELL
Payment of exercise price or tax liability
|
Direct |
3,770
-8.37%
|
$539,110
$143.83 P/Share
|
|
Mar 21
2021
|
Joseph Hunter Saklad EVP, Chief Supply Chain Office |
BUY
Grant, award, or other acquisition
|
Direct |
9,013
+16.68%
|
-
|
|
Mar 21
2021
|
Robert Joseph Poirier VP, CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-21.22%
|
$88,088
$143.83 P/Share
|
|
Mar 21
2021
|
Robert Joseph Poirier VP, CAO |
BUY
Grant, award, or other acquisition
|
Direct |
1,800
+38.27%
|
-
|
|
Mar 16
2021
|
Shelly Radue Ibach President and CEO |
BUY
Bona fide gift
|
Indirect |
22,179
+13.84%
|
-
|
|
Mar 16
2021
|
Shelly Radue Ibach President and CEO |
SELL
Bona fide gift
|
Direct |
22,179
-100.0%
|
-
|
|
Mar 16
2021
|
Shelly Radue Ibach President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,904
-43.25%
|
$2,400,368
$142.1 P/Share
|
|
Mar 15
2021
|
Robert Joseph Poirier VP, CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
65
-5.57%
|
$9,490
$146.97 P/Share
|
|
Mar 11
2021
|
Daniel Alegre Director |
BUY
Grant, award, or other acquisition
|
Direct |
152
+0.65%
|
$21,128
$139.36 P/Share
|
|
Mar 02
2021
|
Samuel R Hellfeld EVP Chief Legal & Risk Officer |
SELL
Open market or private sale
|
Direct |
3,782
-34.51%
|
$552,172
$146.0 P/Share
|
|
Mar 02
2021
|
Shelly Radue Ibach President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-20.37%
|
$1,450,000
$145.22 P/Share
|
|
Mar 02
2021
|
Shelly Radue Ibach President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.93%
|
$180,000
$18.81 P/Share
|
|
Mar 01
2021
|
Robert Joseph Poirier VP, CAO |
SELL
Open market or private sale
|
Direct |
1,636
-58.35%
|
$233,948
$143.09 P/Share
|